{
 "_meta": {
  "sources": [
   {
    "name": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
    "url": "https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf",
    "archived_copy_read": "https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf",
    "published": "01/01/2017",
    "covers": "cumulative doses distributed 01/01/2006 through 12/31/2014"
   },
   {
    "name": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
    "url": "https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf",
    "archived_copy_read": "https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf",
    "published": "04/01/2017",
    "covers": "cumulative doses distributed 01/01/2006 through 12/31/2015"
   },
   {
    "name": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
    "url": "https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf",
    "archived_copy_read": "https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf",
    "published": "11/30/2018",
    "covers": "cumulative doses distributed 01/01/2006 through 12/31/2016"
   },
   {
    "name": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
    "url": "https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf",
    "archived_copy_read": "https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf",
    "published": "11/01/2019",
    "covers": "cumulative doses distributed 01/01/2006 through 12/31/2017"
   },
   {
    "name": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
    "url": "https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf",
    "archived_copy_read": "https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf",
    "published": "04/01/2021",
    "covers": "cumulative doses distributed 01/01/2006 through 12/31/2018"
   },
   {
    "name": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
    "url": "https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf",
    "archived_copy_read": "https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf",
    "published": "08/01/2022",
    "covers": "cumulative doses distributed 01/01/2006 through 12/31/2019"
   },
   {
    "name": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
    "url": "https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf",
    "archived_copy_read": "https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf",
    "published": "09/01/2023",
    "covers": "cumulative doses distributed 01/01/2006 through 12/31/2021"
   },
   {
    "name": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
    "url": "https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf",
    "archived_copy_read": "https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf",
    "published": "09/01/2024",
    "covers": "cumulative doses distributed 01/01/2006 through 12/31/2022"
   },
   {
    "name": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
    "url": "https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf",
    "archived_copy_read": "https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf",
    "published": "09/01/2025",
    "covers": "cumulative doses distributed 01/01/2006 through 12/31/2023"
   },
   {
    "name": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
    "url": "https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf",
    "archived_copy_read": "https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf",
    "published": "09/01/2026",
    "covers": "cumulative doses distributed 01/01/2006 through 12/31/2024"
   },
   {
    "name": "CDC FluVaxView Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season (data.cdc.gov ph8r-wzxn)",
    "url": "https://data.cdc.gov/Flu-Vaccinations/Weekly-Cumulative-Doses-in-Millions-of-Influenza-V/ph8r-wzxn/about_data",
    "published": "dashboard page published 2024-09-16, updated 2025-12-03; dataset current through 03/07/2026; downloaded 2026-10-09",
    "dashboard": "https://www.cdc.gov/fluvaxview/dashboard/vaccine-doses-distributed.html"
   },
   {
    "name": "CDC archived per-season \"Seasonal Influenza Vaccine Total Doses Distributed\" pages, 2011-12 through 2017-18",
    "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/vaccinesupply-2011.htm (and -2012 ... -2017)",
    "published": "per-season pages; final weekly updates Feb-Mar at the end of each season"
   },
   {
    "name": "CDC Adjusted and Unadjusted Flu Vaccine Doses Distributed: 2018-2019 - 2021-2022",
    "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/unadjusted-archive.htm",
    "published": "last reviewed 2023-01-06"
   },
   {
    "name": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc)",
    "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
    "published": "rows last updated 2023-05-11 (data through 2023-05-10)"
   },
   {
    "name": "Hause AM, Moro PL, Baggs J, et al. Early Safety Findings Among Persons Aged >=60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024. MMWR 2024;73(21):489-494",
    "url": "https://www.cdc.gov/mmwr/volumes/73/wr/mm7321a3.htm",
    "published": "2024-05-30"
   },
   {
    "name": "Hesse EM et al. MMWR 2019;68(4):91-94 (Shingrix postlicensure safety surveillance)",
    "url": "https://www.cdc.gov/mmwr/volumes/68/wr/mm6804a4.htm",
    "published": "2019-02-01"
   }
  ],
  "notes": "HRSA publishes ONLY cumulative doses distributed since 01/01/2006; there is no per-year table. Per-year HRSA values here are differences between successive editions (value_type=derived_difference_of_cumulative_editions) and assume HRSA did not revise earlier years. Cumulative endpoints available: 2014, 2015, 2016, 2017, 2018, 2019, 2021, 2022, 2023, 2024. No edition ever printed a through-2020 total; the column jumped from 12/31/2019 to 12/31/2021. So 2020 and 2021 appear only as one combined '2020-2021' increment. There is no annual split within 2006-2014. HRSA edition headers sometimes advance before the dose figures do. The Apr 2020 edition (header 'through 12/31/2018') repeats the through-2017 doses. The Oct 2022 edition (header 'through 12/31/2021') repeats the through-2019 doses. Each endpoint was therefore taken from an edition whose dose figures had actually changed, and the increments are consistent with about one year of distribution (two years for 2020-2021). Source typos: the 03/2023 and 09/2023 editions print Rotavirus 1,422,658,212. That row is flagged, and rotavirus is given only as a 2020-2022 increment. The 01/01/2026 edition prints Hep B-HIB 240,789,709 (a copy of the Hep A value), so the 09/01/2025 edition, which covers the same dates, was used for 2023. Zero increments (DT after 2016, DTaP-HIB, Hep B-HIB, Measles, Mumps, Rubella, Tetanus, DTP, OPV) are left out of the derived rows. They mean no new doses were distributed. The 2024 HRSA increment for Pneumococcal Conjugate is unusually large: 47.6M, against 6.7-29.9M a year in 2015-2023 (the series had been declining, to 6.7M in 2023). It may reflect adult PCV20/PCV21 use, but this is unverified. HRSA influenza figures are rounded to 0.1M and, per HRSA, come from CDC FluFinder. The HRSA increment for year Y roughly matches CDC's (Y-1)-Y season for 2019, 2022 and 2023, but not for 2024 (134.0M vs CDC 2023-24 at 157.7M). HRSA's printed caveat: doses are manufacturer self-reported distribution data, an estimate of national distribution, and do not represent administration. For CDC flu rows, 'year' is the season string. Values from 2018-19 on are CDC's adjusted totals, and the unadjusted originals are listed separately. COVID figures are cumulative doses administered (and distributed) through the dataset's end on 2023-05-10. Annual COVID values are computed differences of the cumulative totals. counts_toward is only a suggested component mapping and does not allocate doses. DT, Td, Tetanus and Pertussis map to dtap, and single-antigen Measles, Mumps, Rubella and MR map to mmr. All HRSA PDFs were read from Internet Archive copies, because hrsa.gov returned HTTP 403 to automated fetches. Each source entry gives the Wayback URL in archived_copy_read.",
  "retrieved": "2026-10-09"
 },
 "rows": [
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 712347,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"DT\"; printed value 712,347; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 83052184,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"DTaP\"; printed value 83,052,184; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 51305397,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"DTaP-Hep B-IPV\"; printed value 51,305,397; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "DTaP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 1135474,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"DTaP-HIB\"; printed value 1,135,474; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 46401211,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"DTaP-IPV-HIB\"; printed value 46,401,211; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 15490820,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"DTap-IPV\"; printed value 15,490,820; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "DTP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"DTP\"; printed value 0; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "DTP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"DTP-HIB\"; printed value 0; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 12740305,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Hep A-Hep B\"; printed value 12,740,305; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Hep B-HIB",
   "counts_toward": [
    "hepatitis-b",
    "hib"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 4787457,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Hep B-HIB\"; printed value 4,787,457; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 136935713,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Hepatitis A (Hep A)\"; printed value 136,935,713; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 143946953,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Hepatitis B (Hep B)\"; printed value 143,946,953; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 93160376,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"HIB\"; printed value 93,160,376; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 77506945,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"HPV\"; printed value 77,506,945; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 1078000000,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Influenza\"; printed value 1,078,000,000; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 62344612,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"IPV\"; printed value 62,344,612; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Measles",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 135660,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Measles\"; printed value 135,660; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 64004175,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Meningococcal\"; printed value 64,004,175; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 80115475,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"MMR\"; printed value 80,115,475; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Mumps",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 110749,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Mumps\"; printed value 110,749; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 14403057,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"MMR-Varicella\"; printed value 14,403,057; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "OPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"OPV\"; printed value 0; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 150497243,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Pneumococcal Conjugate\"; printed value 150,497,243; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 79636437,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Rotavirus\"; printed value 79,636,437; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Rubella",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 422548,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Rubella\"; printed value 422,548; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 57940972,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Td\"; printed value 57,940,972; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 177160298,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Tdap\"; printed value 177,160,298; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Tetanus",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 3836052,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Tetanus\"; printed value 3,836,052; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 96646081,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Varicella\"; printed value 96,646,081; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2006-2014",
   "period_start": "2006-01-01",
   "period_end": "2014-12-31",
   "doses": 2532428541,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 01/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2014 (Source: CDC)\", row \"Grand Total\"; printed value 2,532,428,541; read from https://web.archive.org/web/20170923140846/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/statisticsreport.pdf"
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 756377,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"DT\"; printed value 756,377; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 88814104,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"DTaP\"; printed value 88,814,104; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 56700877,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"DTaP-Hep B-IPV\"; printed value 56,700,877; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "DTaP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 1135474,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"DTaP-HIB\"; printed value 1,135,474; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 52242336,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"DTaP-IPV-HIB\"; printed value 52,242,336; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 18613490,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"DTap-IPV\"; printed value 18,613,490; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "DTP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"DTP\"; printed value 0; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "DTP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"DTP-HIB\"; printed value 0; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 13767345,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Hep A-Hep B\"; printed value 13,767,345; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Hep B-HIB",
   "counts_toward": [
    "hepatitis-b",
    "hib"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 4787457,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Hep B-HIB\"; printed value 4,787,457; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 150276481,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Hepatitis A (Hep A)\"; printed value 150,276,481; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 158988970,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Hepatitis B (Hep B)\"; printed value 158,988,970; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 101459227,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"HIB\"; printed value 101,459,227; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 89696704,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"HPV\"; printed value 89,696,704; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 1226400000,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Influenza\"; printed value 1,226,400,000; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 65399472,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"IPV\"; printed value 65,399,472; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Measles",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 135660,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Measles\"; printed value 135,660; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 70797701,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Meningococcal\"; printed value 70,797,701; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 87990038,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"MMR\"; printed value 87,990,038; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Mumps",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 110749,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Mumps\"; printed value 110,749; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 18023247,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"MMR-Varicella\"; printed value 18,023,247; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "OPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"OPV\"; printed value 0; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 180357916,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Pneumococcal Conjugate\"; printed value 180,357,916; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 89501227,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Rotavirus\"; printed value 89,501,227; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Rubella",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 422548,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Rubella\"; printed value 422,548; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 60068722,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Td\"; printed value 60,068,722; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 202021173,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Tdap\"; printed value 202,021,173; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Tetanus",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 3836052,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Tetanus\"; printed value 3,836,052; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 103643469,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Varicella\"; printed value 103,643,469; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2006-2015",
   "period_start": "2006-01-01",
   "period_end": "2015-12-31",
   "doses": 2845946816,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2017",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2015 (Source: CDC)\", row \"Grand Total\"; printed value 2,845,946,816; read from https://web.archive.org/web/20190502232736/https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/monthlywebsitestats04_01_17.pdf"
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 794777,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"DT\"; printed value 794,777; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 95532634,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"DTaP\"; printed value 95,532,634; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 63245627,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"DTaP-Hep B-IPV\"; printed value 63,245,627; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "DTaP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 1135474,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"DTaP-HIB\"; printed value 1,135,474; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 21143570,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"DTaP-IPV\"; printed value 21,143,570; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 56635096,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"DTap-IPV-HIB\"; printed value 56,635,096; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "DTP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"DTP\"; printed value 0; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "DTP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"DTP-HIB\"; printed value 0; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 14706195,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Hep A-Hep B\"; printed value 14,706,195; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Hep B-HIB",
   "counts_toward": [
    "hepatitis-b",
    "hib"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 4787457,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Hep B-HIB\"; printed value 4,787,457; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 163305725,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Hepatitis A (Hep A)\"; printed value 163,305,725; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 172993779,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Hepatitis B (Hep B)\"; printed value 172,993,779; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 111200358,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"HIB\"; printed value 111,200,358; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 101405935,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"HPV\"; printed value 101,405,935; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 1372400000,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Influenza\"; printed value 1,372,400,000; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 69510722,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"IPV\"; printed value 69,510,722; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Measles",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 135660,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Measles\"; printed value 135,660; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 82762503,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Meningococcal\"; printed value 82,762,503; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 94815650,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"MMR\"; printed value 94,815,650; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Mumps",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 110749,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Mumps\"; printed value 110,749; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 21349409,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"MMR-Varicella\"; printed value 21,349,409; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Nonqualified",
   "counts_toward": [],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Nonqualified\"; printed value 0; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "OPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"OPV\"; printed value 0; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 206003646,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Pneumococcal Conjugate\"; printed value 206,003,646; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 98664187,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Rotavirus\"; printed value 98,664,187; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Rubella",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 422548,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Rubella\"; printed value 422,548; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 61869752,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Td\"; printed value 61,869,752; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 225013338,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Tdap\"; printed value 225,013,338; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Tetanus",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 3836052,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Tetanus\"; printed value 3,836,052; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Unspecified",
   "counts_toward": [],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Unspecified\"; printed value 0; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 110095393,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Varicella\"; printed value 110,095,393; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2006-2016",
   "period_start": "2006-01-01",
   "period_end": "2016-12-31",
   "doses": 3153876236,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/30/2018",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2016 (Source: CDC)\", row \"Grand Total\"; printed value 3,153,876,236; read from https://web.archive.org/web/20181217183121/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/monthly-stats-december-2018.pdf"
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 794777,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"DT\"; printed value 794,777; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 101073594,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"DTaP\"; printed value 101,073,594; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 68764777,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"DTaP-Hep B-IPV\"; printed value 68,764,777; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "DTaP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 1135474,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"DTaP-HIB\"; printed value 1,135,474; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 24237580,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"DTaP-IPV\"; printed value 24,237,580; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 62397611,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"DTap-IPV-HIB\"; printed value 62,397,611; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "DTP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"DTP\"; printed value 0; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "DTP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"DTP-HIB\"; printed value 0; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 15826685,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Hep A-Hep B\"; printed value 15,826,685; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Hep B-HIB",
   "counts_toward": [
    "hepatitis-b",
    "hib"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 4787457,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Hep B-HIB\"; printed value 4,787,457; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 176194118,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Hepatitis A (Hep A)\"; printed value 176,194,118; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 185428393,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Hepatitis B (Hep B)\"; printed value 185,428,393; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 119947400,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"HIB\"; printed value 119,947,400; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 111677552,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"HPV\"; printed value 111,677,552; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 1518400000,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Influenza\"; printed value 1,518,400,000; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 72962512,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"IPV\"; printed value 72,962,512; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Measles",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 135660,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Measles\"; printed value 135,660; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 94113218,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Meningococcal\"; printed value 94,113,218; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 101501714,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"MMR\"; printed value 101,501,714; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 24798297,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"MMR-Varicella\"; printed value 24,798,297; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Mumps",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 110749,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Mumps\"; printed value 110,749; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Nonqualified",
   "counts_toward": [],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Nonqualified\"; printed value 0; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "OPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"OPV\"; printed value 0; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 228588846,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Pneumococcal Conjugate\"; printed value 228,588,846; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 107678219,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Rotavirus\"; printed value 107,678,219; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Rubella",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 422548,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Rubella\"; printed value 422,548; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 65170306,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Td\"; printed value 65,170,306; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 248258803,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Tdap\"; printed value 248,258,803; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Tetanus",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 3836052,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Tetanus\"; printed value 3,836,052; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Unspecified",
   "counts_toward": [],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Unspecified\"; printed value 0; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 116063014,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Varicella\"; printed value 116,063,014; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2006-2017",
   "period_start": "2006-01-01",
   "period_end": "2017-12-31",
   "doses": 3454269356,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 11/01/2019",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2017 (Source: CDC)\", row \"Grand Total\"; printed value 3,454,269,356; read from https://web.archive.org/web/20191113105533/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-november-2019.pdf"
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 794777,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"DT\"; printed value 794,777; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 105474077,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"DTaP\"; printed value 105,474,077; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 74255807,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"DTaP-Hep B-IPV\"; printed value 74,255,807; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "DTaP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 1135474,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"DTaP-HIB\"; printed value 1,135,474; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 27884804,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"DTaP-IPV\"; printed value 27,884,804; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 68409736,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"DTap-IPV-HIB\"; printed value 68,409,736; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "DTP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"DTP\"; printed value 0; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "DTP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"DTP-HIB\"; printed value 0; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 16923878,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Hep A-Hep B\"; printed value 16,923,878; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Hep B-HIB",
   "counts_toward": [
    "hepatitis-b",
    "hib"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 4787457,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Hep B-HIB\"; printed value 4,787,457; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 189707214,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Hepatitis A (Hep A)\"; printed value 189,707,214; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 198868169,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Hepatitis B (Hep B)\"; printed value 198,868,169; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 128789396,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"HIB\"; printed value 128,789,396; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 121642555,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"HPV\"; printed value 121,642,555; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 1672400000,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Influenza\"; printed value 1,672,400,000; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 75537282,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"IPV\"; printed value 75,537,282; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Measles",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 135660,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Measles\"; printed value 135,660; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 106233254,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Meningococcal\"; printed value 106,233,254; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 108389441,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"MMR\"; printed value 108,389,441; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 28376497,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"MMR-Varicella\"; printed value 28,376,497; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Mumps",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 110749,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Mumps\"; printed value 110,749; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Nonqualified",
   "counts_toward": [],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Nonqualified\"; printed value 0; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "OPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"OPV\"; printed value 0; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 250151136,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Pneumococcal Conjugate\"; printed value 250,151,136; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 116651363,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Rotavirus\"; printed value 116,651,363; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Rubella",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 422548,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Rubella\"; printed value 422,548; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 68120632,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Td\"; printed value 68,120,632; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 270851285,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Tdap\"; printed value 270,851,285; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Tetanus",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 3836052,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Tetanus\"; printed value 3,836,052; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Unspecified",
   "counts_toward": [],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Unspecified\"; printed value 0; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 121855108,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Varicella\"; printed value 121,855,108; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2006-2018",
   "period_start": "2006-01-01",
   "period_end": "2018-12-31",
   "doses": 3761744351,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 04/01/2021",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2018 (Source: CDC)\", row \"Grand Total\"; printed value 3,761,744,351; read from https://web.archive.org/web/20210413111535/https://www.hrsa.gov/sites/default/files/hrsa/vaccine-compensation/data/data-statistics-report.pdf"
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 794777,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"DT\"; printed value 794,777; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 109991074,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"DTaP\"; printed value 109,991,074; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 79798141,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"DTaP-Hep B-IPV\"; printed value 79,798,141; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "DTaP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 1135474,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"DTaP-HIB\"; printed value 1,135,474; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 31439498,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"DTaP-IPV\"; printed value 31,439,498; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 74403716,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"DTap-IPV-HIB\"; printed value 74,403,716; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "DTP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"DTP\"; printed value 0; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "DTP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"DTP-HIB\"; printed value 0; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 17946038,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Hep A-Hep B\"; printed value 17,946,038; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Hep B-HIB",
   "counts_toward": [
    "hepatitis-b",
    "hib"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 4787457,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Hep B-HIB\"; printed value 4,787,457; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 203339060,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Hepatitis A (Hep A)\"; printed value 203,339,060; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 216772259,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Hepatitis B (Hep B)\"; printed value 216,772,259; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 137675315,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"HIB\"; printed value 137,675,315; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 132062306,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"HPV\"; printed value 132,062,306; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 1842400000,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Influenza\"; printed value 1,842,400,000; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 78237532,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"IPV\"; printed value 78,237,532; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Measles",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 135660,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Measles\"; printed value 135,660; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 119054485,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Meningococcal\"; printed value 119,054,485; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 116647585,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"MMR\"; printed value 116,647,585; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 32226723,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"MMR-Varicella\"; printed value 32,226,723; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Mumps",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 110749,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Mumps\"; printed value 110,749; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Nonqualified",
   "counts_toward": [],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Nonqualified\"; printed value 0; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "OPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"OPV\"; printed value 0; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 269907936,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Pneumococcal Conjugate\"; printed value 269,907,936; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 125787826,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Rotavirus\"; printed value 125,787,826; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Rubella",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 422548,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Rubella\"; printed value 422,548; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 71408785,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Td\"; printed value 71,408,785; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 294534882,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Tdap\"; printed value 294,534,882; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Tetanus",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 3836052,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Tetanus\"; printed value 3,836,052; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Unspecified",
   "counts_toward": [],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Unspecified\"; printed value 0; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 127901171,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Varicella\"; printed value 127,901,171; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2006-2019",
   "period_start": "2006-01-01",
   "period_end": "2019-12-31",
   "doses": 4092757049,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 08/01/2022",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2019 (Source: CDC)\", row \"Grand Total\"; printed value 4,092,757,049; read from https://web.archive.org/web/20220808171349/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-08-01-22.pdf"
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 794777,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"DT\"; printed value 794,777; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 119588927,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"DTaP\"; printed value 119,588,927; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 89690234,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"DTaP-Hep B-IPV\"; printed value 89,690,234; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "DTaP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 1135474,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"DTaP-HIB\"; printed value 1,135,474; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 35717741,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"DTaP-IPV\"; printed value 35,717,741; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 85135961,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"DTaP-IPV-HIB\"; printed value 85,135,961; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB-Hep B",
   "counts_toward": [
    "dtap",
    "polio",
    "hib",
    "hepatitis-b"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 464070,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"DTaP-IPV-HIB-Hep B\"; printed value 464,070; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "DTP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"DTP\"; printed value 0; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "DTP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"DTP-HIB\"; printed value 0; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 19067612,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Hep A-Hep B\"; printed value 19,067,612; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Hep B-HIB",
   "counts_toward": [
    "hepatitis-b",
    "hib"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 4787457,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Hep B-HIB\"; printed value 4,787,457; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 221388946,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Hepatitis A (Hep A)\"; printed value 221,388,946; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 238582570,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Hepatitis B (Hep B)\"; printed value 238,582,570; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 152436021,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"HIB\"; printed value 152,436,021; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 149352148,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"HPV\"; printed value 149,352,148; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 2231400000,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Influenza\"; printed value 2,231,400,000; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 83134982,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"IPV\"; printed value 83,134,982; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Measles",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 135660,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Measles\"; printed value 135,660; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 140401298,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Meningococcal\"; printed value 140,401,298; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 127871467,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"MMR\"; printed value 127,871,467; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 39223326,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"MMR-Varicella\"; printed value 39,223,326; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Mumps",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 110749,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Mumps\"; printed value 110,749; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Nonqualified",
   "counts_toward": [],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Nonqualified\"; printed value 0; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "OPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"OPV\"; printed value 0; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 303138568,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Pneumococcal Conjugate\"; printed value 303,138,568; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 1422658212,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Rotavirus\"; printed value 1,422,658,212; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf",
   "suspected_source_error": "Printed value is inconsistent with adjacent editions (Rotavirus 125,787,826 through 2019; 150,866,652 through 2022) - apparently an extra digit; Grand Total inflated accordingly. Same value printed in the 03/2023 edition. Do not use."
  },
  {
   "source_category": "Rubella",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 422548,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Rubella\"; printed value 422,548; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 76709653,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Td\"; printed value 76,709,653; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 335133138,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Tdap\"; printed value 335,133,138; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Tetanus",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 3836052,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Tetanus\"; printed value 3,836,052; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Unspecified",
   "counts_toward": [],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Unspecified\"; printed value 0; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 138414086,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Varicella\"; printed value 138,414,086; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf"
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2006-2021",
   "period_start": "2006-01-01",
   "period_end": "2021-12-31",
   "doses": 6020731677,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2023",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2021 (Source: CDC)\", row \"Grand Total\"; printed value 6,020,731,677; read from https://web.archive.org/web/20230929093140/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-23.pdf",
   "suspected_source_error": "Printed value is inconsistent with adjacent editions (Rotavirus 125,787,826 through 2019; 150,866,652 through 2022) - apparently an extra digit; Grand Total inflated accordingly. Same value printed in the 03/2023 edition. Do not use."
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 794777,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"DT\"; printed value 794,777; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 122237653,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"DTaP\"; printed value 122,237,653; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 94331585,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"DTaP-Hep B-IPV\"; printed value 94,331,585; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "DTaP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 1135474,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"DTaP-HIB\"; printed value 1,135,474; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 40456384,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"DTaP-IPV\"; printed value 40,456,384; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 89568786,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"DTaP-IPV-HIB\"; printed value 89,568,786; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB-Hep B",
   "counts_toward": [
    "dtap",
    "polio",
    "hib",
    "hepatitis-b"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 2021770,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"DTaP-IPV-HIB-Hep B\"; printed value 2,021,770; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "DTP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"DTP\"; printed value 0; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "DTP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"DTP-HIB\"; printed value 0; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 19811507,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Hep A-Hep B\"; printed value 19,811,507; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Hep B-HIB",
   "counts_toward": [
    "hepatitis-b",
    "hib"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 4787457,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Hep B-HIB\"; printed value 4,787,457; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 231034565,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Hepatitis A (Hep A)\"; printed value 231,034,565; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 248816802,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Hepatitis B (Hep B)\"; printed value 248,816,802; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 159451493,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"HIB\"; printed value 159,451,493; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 158878541,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"HPV\"; printed value 158,878,541; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 2407000000,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Influenza\"; printed value 2,407,000,000; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 85816592,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"IPV\"; printed value 85,816,592; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Measles",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 135660,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Measles\"; printed value 135,660; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 152566593,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Meningococcal\"; printed value 152,566,593; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 134424338,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"MMR\"; printed value 134,424,338; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 42936444,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"MMR-Varicella\"; printed value 42,936,444; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Mumps",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 110749,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Mumps\"; printed value 110,749; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Nonqualified",
   "counts_toward": [],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Nonqualified\"; printed value 0; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "OPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"OPV\"; printed value 0; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 317159908,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Pneumococcal Conjugate\"; printed value 317,159,908; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 150866652,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Rotavirus\"; printed value 150,866,652; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Rubella",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 422548,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Rubella\"; printed value 422,548; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 79432193,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Td\"; printed value 79,432,193; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 358134237,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Tdap\"; printed value 358,134,237; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Tetanus",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 3836052,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Tetanus\"; printed value 3,836,052; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Unspecified",
   "counts_toward": [],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Unspecified\"; printed value 0; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 143906028,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Varicella\"; printed value 143,906,028; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2006-2022",
   "period_start": "2006-01-01",
   "period_end": "2022-12-31",
   "doses": 5050074788,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2024",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2022 (Source: CDC)\", row \"Grand Total\"; printed value 5,050,074,788; read from https://web.archive.org/web/20240907145541/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-9-1-24.pdf"
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 794777,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"DT\"; printed value 794,777; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 126028897,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"DTaP\"; printed value 126,028,897; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 98385954,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"DTaP-Hep B-IPV\"; printed value 98,385,954; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "DTaP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 1135474,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"DTaP-HIB\"; printed value 1,135,474; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 43760958,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"DTaP-IPV\"; printed value 43,760,958; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 93153256,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"DTaP-IPV-HIB\"; printed value 93,153,256; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB-Hep B",
   "counts_toward": [
    "dtap",
    "polio",
    "hib",
    "hepatitis-b"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 4339724,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"DTaP-IPV-HIB-Hep B\"; printed value 4,339,724; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "DTP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"DTP\"; printed value 0; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "DTP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"DTP-HIB\"; printed value 0; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 20818627,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Hep A-Hep B\"; printed value 20,818,627; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Hep B-HIB",
   "counts_toward": [
    "hepatitis-b",
    "hib"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 4787457,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Hep B-HIB\"; printed value 4,787,457; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 240789709,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Hepatitis A (Hep A)\"; printed value 240,789,709; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 258491577,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Hepatitis B (Hep B)\"; printed value 258,491,577; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 166063276,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"HIB\"; printed value 166,063,276; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 167752042,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"HPV\"; printed value 167,752,042; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 2580400000,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Influenza\"; printed value 2,580,400,000; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 88334742,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"IPV\"; printed value 88,334,742; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Measles",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 135660,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Measles\"; printed value 135,660; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 164420532,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Meningococcal\"; printed value 164,420,532; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 140498011,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"MMR\"; printed value 140,498,011; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 46677170,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"MMR-Varicella\"; printed value 46,677,170; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Mumps",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 110749,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Mumps\"; printed value 110,749; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Nonqualified",
   "counts_toward": [],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Nonqualified\"; printed value 0; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "OPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"OPV\"; printed value 0; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 323816348,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Pneumococcal Conjugate\"; printed value 323,816,348; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 159130001,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Rotavirus\"; printed value 159,130,001; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Rubella",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 422548,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Rubella\"; printed value 422,548; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 81901303,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Td\"; printed value 81,901,303; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 381669652,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Tdap\"; printed value 381,669,652; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Tetanus",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 3836052,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Tetanus\"; printed value 3,836,052; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Unspecified",
   "counts_toward": [],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Unspecified\"; printed value 0; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 149656036,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Varicella\"; printed value 149,656,036; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2006-2023",
   "period_start": "2006-01-01",
   "period_end": "2023-12-31",
   "doses": 5347310532,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2025",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2023 (Source: CDC)\", row \"Grand Total\"; printed value 5,347,310,532; read from https://web.archive.org/web/20250904205420/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-25.pdf"
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 794777,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"DT\"; printed value 794,777; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 129682700,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"DTaP\"; printed value 129,682,700; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 102101782,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"DTaP-Hep B-IPV\"; printed value 102,101,782; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "DTaP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 1135474,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"DTaP-HIB\"; printed value 1,135,474; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 47563529,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"DTaP-IPV\"; printed value 47,563,529; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 96295911,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"DTaP-IPV-HIB\"; printed value 96,295,911; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "DTaP-IPV-HIB-Hep B",
   "counts_toward": [
    "dtap",
    "polio",
    "hib",
    "hepatitis-b"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 7038594,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"DtaP-IPV-HIB-Hep B\"; printed value 7,038,594; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "DTP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"DTP\"; printed value 0; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "DTP-HIB",
   "counts_toward": [
    "dtap",
    "hib"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"DTP-HIB\"; printed value 0; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 21957724,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Hep A-Hep B\"; printed value 21,957,724; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 250400774,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Hepatitis A (Hep A)\"; printed value 250,400,774; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 270766553,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Hepatitis B (Hep B)\"; printed value 270,766,553; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Hep B-HIB",
   "counts_toward": [
    "hepatitis-b",
    "hib"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 4787457,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Hep B-HIB\"; printed value 4,787,457; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 172182073,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"HIB\"; printed value 172,182,073; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 177457602,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"HPV\"; printed value 177,457,602; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 2714400000,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Influenza\"; printed value 2,714,400,000; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 91622882,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"IPV\"; printed value 91,622,882; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Measles",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 135660,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Measles\"; printed value 135,660; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 177573215,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 2, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Meningococcal\"; printed value 177,573,215; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 146684769,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"MMR\"; printed value 146,684,769; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 50474023,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"MMR-Varicella\"; printed value 50,474,023; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "MR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"MR\"; printed value 0; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Mumps",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 110749,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Mumps\"; printed value 110,749; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Nonqualified",
   "counts_toward": [],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Nonqualified\"; printed value 0; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "OPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"OPV\"; printed value 0; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Pertussis",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Pertussis\"; printed value 0; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 371374550,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Pneumococcal Conjugate\"; printed value 371,374,550; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 167131097,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Rotavirus\"; printed value 167,131,097; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Rubella",
   "counts_toward": [
    "mmr"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 422548,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Rubella\"; printed value 422,548; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 83871193,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Td\"; printed value 83,871,193; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 406747693,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Tdap\"; printed value 406,747,693; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Tetanus",
   "counts_toward": [
    "dtap"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 3836052,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Tetanus\"; printed value 3,836,052; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Unspecified",
   "counts_toward": [],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Unspecified\"; printed value 0; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 155446100,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Varicella\"; printed value 155,446,100; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2006-2024",
   "period_start": "2006-01-01",
   "period_end": "2024-12-31",
   "doses": 5651995481,
   "measure": "distributed",
   "value_type": "cumulative_as_printed",
   "source": "HRSA VICP Monthly Statistics Report, updated 09/01/2026",
   "location_in_source": "Page 3, table \"VICP Adjudication Categories, by Alleged Vaccine for Petitions Filed Since the Inclusion of Influenza as an Eligible Vaccine\", column \"Number of Doses Distributed in the U.S., 01/01/2006 through 12/31/2024 (Source: CDC)\", row \"Grand Total\"; printed value 5,651,995,481; read from https://web.archive.org/web/20260921183008/https://www.hrsa.gov/sites/default/files/hrsa/vicp/vicp-stats-09-01-26.pdf"
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 44030,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"DT\", doses-distributed column: cumulative through 12/31/2015 (756,377) minus cumulative through 12/31/2014 (712,347). Computed, not printed."
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 5761920,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"DTaP\", doses-distributed column: cumulative through 12/31/2015 (88,814,104) minus cumulative through 12/31/2014 (83,052,184). Computed, not printed."
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 5395480,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"DTaP-Hep B-IPV\", doses-distributed column: cumulative through 12/31/2015 (56,700,877) minus cumulative through 12/31/2014 (51,305,397). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 5841125,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"DTaP-IPV-HIB\", doses-distributed column: cumulative through 12/31/2015 (52,242,336) minus cumulative through 12/31/2014 (46,401,211). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 3122670,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"DTaP-IPV\", doses-distributed column: cumulative through 12/31/2015 (18,613,490) minus cumulative through 12/31/2014 (15,490,820). Computed, not printed."
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 1027040,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Hep A-Hep B\", doses-distributed column: cumulative through 12/31/2015 (13,767,345) minus cumulative through 12/31/2014 (12,740,305). Computed, not printed."
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 13340768,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Hepatitis A (Hep A)\", doses-distributed column: cumulative through 12/31/2015 (150,276,481) minus cumulative through 12/31/2014 (136,935,713). Computed, not printed."
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 15042017,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Hepatitis B (Hep B)\", doses-distributed column: cumulative through 12/31/2015 (158,988,970) minus cumulative through 12/31/2014 (143,946,953). Computed, not printed."
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 8298851,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"HIB\", doses-distributed column: cumulative through 12/31/2015 (101,459,227) minus cumulative through 12/31/2014 (93,160,376). Computed, not printed."
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 12189759,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"HPV\", doses-distributed column: cumulative through 12/31/2015 (89,696,704) minus cumulative through 12/31/2014 (77,506,945). Computed, not printed."
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 148400000,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Influenza\", doses-distributed column: cumulative through 12/31/2015 (1,226,400,000) minus cumulative through 12/31/2014 (1,078,000,000). Computed, not printed."
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 3054860,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"IPV\", doses-distributed column: cumulative through 12/31/2015 (65,399,472) minus cumulative through 12/31/2014 (62,344,612). Computed, not printed."
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 6793526,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Meningococcal\", doses-distributed column: cumulative through 12/31/2015 (70,797,701) minus cumulative through 12/31/2014 (64,004,175). Computed, not printed."
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 7874563,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"MMR\", doses-distributed column: cumulative through 12/31/2015 (87,990,038) minus cumulative through 12/31/2014 (80,115,475). Computed, not printed."
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 3620190,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"MMR-Varicella\", doses-distributed column: cumulative through 12/31/2015 (18,023,247) minus cumulative through 12/31/2014 (14,403,057). Computed, not printed."
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 29860673,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Pneumococcal Conjugate\", doses-distributed column: cumulative through 12/31/2015 (180,357,916) minus cumulative through 12/31/2014 (150,497,243). Computed, not printed."
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 9864790,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Rotavirus\", doses-distributed column: cumulative through 12/31/2015 (89,501,227) minus cumulative through 12/31/2014 (79,636,437). Computed, not printed."
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 2127750,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Td\", doses-distributed column: cumulative through 12/31/2015 (60,068,722) minus cumulative through 12/31/2014 (57,940,972). Computed, not printed."
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 24860875,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Tdap\", doses-distributed column: cumulative through 12/31/2015 (202,021,173) minus cumulative through 12/31/2014 (177,160,298). Computed, not printed."
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 6997388,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Varicella\", doses-distributed column: cumulative through 12/31/2015 (103,643,469) minus cumulative through 12/31/2014 (96,646,081). Computed, not printed."
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": 2015,
   "period_start": "2015-01-01",
   "period_end": "2015-12-31",
   "doses": 313518275,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2017 minus 01/01/2017",
   "location_in_source": "Row \"Grand Total\", doses-distributed column: cumulative through 12/31/2015 (2,845,946,816) minus cumulative through 12/31/2014 (2,532,428,541). Computed, not printed."
  },
  {
   "source_category": "DT",
   "counts_toward": [
    "dtap"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 38400,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"DT\", doses-distributed column: cumulative through 12/31/2016 (794,777) minus cumulative through 12/31/2015 (756,377). Computed, not printed."
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 6718530,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"DTaP\", doses-distributed column: cumulative through 12/31/2016 (95,532,634) minus cumulative through 12/31/2015 (88,814,104). Computed, not printed."
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 6544750,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"DTaP-Hep B-IPV\", doses-distributed column: cumulative through 12/31/2016 (63,245,627) minus cumulative through 12/31/2015 (56,700,877). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 2530080,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"DTaP-IPV\", doses-distributed column: cumulative through 12/31/2016 (21,143,570) minus cumulative through 12/31/2015 (18,613,490). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 4392760,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"DTaP-IPV-HIB\", doses-distributed column: cumulative through 12/31/2016 (56,635,096) minus cumulative through 12/31/2015 (52,242,336). Computed, not printed."
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 938850,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Hep A-Hep B\", doses-distributed column: cumulative through 12/31/2016 (14,706,195) minus cumulative through 12/31/2015 (13,767,345). Computed, not printed."
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 13029244,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Hepatitis A (Hep A)\", doses-distributed column: cumulative through 12/31/2016 (163,305,725) minus cumulative through 12/31/2015 (150,276,481). Computed, not printed."
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 14004809,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Hepatitis B (Hep B)\", doses-distributed column: cumulative through 12/31/2016 (172,993,779) minus cumulative through 12/31/2015 (158,988,970). Computed, not printed."
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 9741131,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"HIB\", doses-distributed column: cumulative through 12/31/2016 (111,200,358) minus cumulative through 12/31/2015 (101,459,227). Computed, not printed."
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 11709231,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"HPV\", doses-distributed column: cumulative through 12/31/2016 (101,405,935) minus cumulative through 12/31/2015 (89,696,704). Computed, not printed."
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 146000000,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Influenza\", doses-distributed column: cumulative through 12/31/2016 (1,372,400,000) minus cumulative through 12/31/2015 (1,226,400,000). Computed, not printed."
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 4111250,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"IPV\", doses-distributed column: cumulative through 12/31/2016 (69,510,722) minus cumulative through 12/31/2015 (65,399,472). Computed, not printed."
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 11964802,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Meningococcal\", doses-distributed column: cumulative through 12/31/2016 (82,762,503) minus cumulative through 12/31/2015 (70,797,701). Computed, not printed."
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 6825612,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"MMR\", doses-distributed column: cumulative through 12/31/2016 (94,815,650) minus cumulative through 12/31/2015 (87,990,038). Computed, not printed."
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 3326162,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"MMR-Varicella\", doses-distributed column: cumulative through 12/31/2016 (21,349,409) minus cumulative through 12/31/2015 (18,023,247). Computed, not printed."
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 25645730,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Pneumococcal Conjugate\", doses-distributed column: cumulative through 12/31/2016 (206,003,646) minus cumulative through 12/31/2015 (180,357,916). Computed, not printed."
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 9162960,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Rotavirus\", doses-distributed column: cumulative through 12/31/2016 (98,664,187) minus cumulative through 12/31/2015 (89,501,227). Computed, not printed."
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 1801030,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Td\", doses-distributed column: cumulative through 12/31/2016 (61,869,752) minus cumulative through 12/31/2015 (60,068,722). Computed, not printed."
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 22992165,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Tdap\", doses-distributed column: cumulative through 12/31/2016 (225,013,338) minus cumulative through 12/31/2015 (202,021,173). Computed, not printed."
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 6451924,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Varicella\", doses-distributed column: cumulative through 12/31/2016 (110,095,393) minus cumulative through 12/31/2015 (103,643,469). Computed, not printed."
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": 2016,
   "period_start": "2016-01-01",
   "period_end": "2016-12-31",
   "doses": 307929420,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/30/2018 minus 04/01/2017",
   "location_in_source": "Row \"Grand Total\", doses-distributed column: cumulative through 12/31/2016 (3,153,876,236) minus cumulative through 12/31/2015 (2,845,946,816). Computed, not printed."
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 5540960,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"DTaP\", doses-distributed column: cumulative through 12/31/2017 (101,073,594) minus cumulative through 12/31/2016 (95,532,634). Computed, not printed."
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 5519150,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"DTaP-Hep B-IPV\", doses-distributed column: cumulative through 12/31/2017 (68,764,777) minus cumulative through 12/31/2016 (63,245,627). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 3094010,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"DTaP-IPV\", doses-distributed column: cumulative through 12/31/2017 (24,237,580) minus cumulative through 12/31/2016 (21,143,570). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 5762515,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"DTaP-IPV-HIB\", doses-distributed column: cumulative through 12/31/2017 (62,397,611) minus cumulative through 12/31/2016 (56,635,096). Computed, not printed."
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 1120490,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Hep A-Hep B\", doses-distributed column: cumulative through 12/31/2017 (15,826,685) minus cumulative through 12/31/2016 (14,706,195). Computed, not printed."
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 12888393,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Hepatitis A (Hep A)\", doses-distributed column: cumulative through 12/31/2017 (176,194,118) minus cumulative through 12/31/2016 (163,305,725). Computed, not printed."
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 12434614,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Hepatitis B (Hep B)\", doses-distributed column: cumulative through 12/31/2017 (185,428,393) minus cumulative through 12/31/2016 (172,993,779). Computed, not printed."
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 8747042,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"HIB\", doses-distributed column: cumulative through 12/31/2017 (119,947,400) minus cumulative through 12/31/2016 (111,200,358). Computed, not printed."
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 10271617,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"HPV\", doses-distributed column: cumulative through 12/31/2017 (111,677,552) minus cumulative through 12/31/2016 (101,405,935). Computed, not printed."
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 146000000,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Influenza\", doses-distributed column: cumulative through 12/31/2017 (1,518,400,000) minus cumulative through 12/31/2016 (1,372,400,000). Computed, not printed."
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 3451790,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"IPV\", doses-distributed column: cumulative through 12/31/2017 (72,962,512) minus cumulative through 12/31/2016 (69,510,722). Computed, not printed."
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 11350715,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Meningococcal\", doses-distributed column: cumulative through 12/31/2017 (94,113,218) minus cumulative through 12/31/2016 (82,762,503). Computed, not printed."
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 6686064,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"MMR\", doses-distributed column: cumulative through 12/31/2017 (101,501,714) minus cumulative through 12/31/2016 (94,815,650). Computed, not printed."
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 3448888,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"MMR-Varicella\", doses-distributed column: cumulative through 12/31/2017 (24,798,297) minus cumulative through 12/31/2016 (21,349,409). Computed, not printed."
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 22585200,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Pneumococcal Conjugate\", doses-distributed column: cumulative through 12/31/2017 (228,588,846) minus cumulative through 12/31/2016 (206,003,646). Computed, not printed."
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 9014032,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Rotavirus\", doses-distributed column: cumulative through 12/31/2017 (107,678,219) minus cumulative through 12/31/2016 (98,664,187). Computed, not printed."
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 3300554,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Td\", doses-distributed column: cumulative through 12/31/2017 (65,170,306) minus cumulative through 12/31/2016 (61,869,752). Computed, not printed."
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 23245465,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Tdap\", doses-distributed column: cumulative through 12/31/2017 (248,258,803) minus cumulative through 12/31/2016 (225,013,338). Computed, not printed."
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 5967621,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Varicella\", doses-distributed column: cumulative through 12/31/2017 (116,063,014) minus cumulative through 12/31/2016 (110,095,393). Computed, not printed."
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": 2017,
   "period_start": "2017-01-01",
   "period_end": "2017-12-31",
   "doses": 300393120,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 11/01/2019 minus 11/30/2018",
   "location_in_source": "Row \"Grand Total\", doses-distributed column: cumulative through 12/31/2017 (3,454,269,356) minus cumulative through 12/31/2016 (3,153,876,236). Computed, not printed."
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 4400483,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"DTaP\", doses-distributed column: cumulative through 12/31/2018 (105,474,077) minus cumulative through 12/31/2017 (101,073,594). Computed, not printed."
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 5491030,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"DTaP-Hep B-IPV\", doses-distributed column: cumulative through 12/31/2018 (74,255,807) minus cumulative through 12/31/2017 (68,764,777). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 3647224,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"DTaP-IPV\", doses-distributed column: cumulative through 12/31/2018 (27,884,804) minus cumulative through 12/31/2017 (24,237,580). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 6012125,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"DTaP-IPV-HIB\", doses-distributed column: cumulative through 12/31/2018 (68,409,736) minus cumulative through 12/31/2017 (62,397,611). Computed, not printed."
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 1097193,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Hep A-Hep B\", doses-distributed column: cumulative through 12/31/2018 (16,923,878) minus cumulative through 12/31/2017 (15,826,685). Computed, not printed."
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 13513096,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Hepatitis A (Hep A)\", doses-distributed column: cumulative through 12/31/2018 (189,707,214) minus cumulative through 12/31/2017 (176,194,118). Computed, not printed."
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 13439776,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Hepatitis B (Hep B)\", doses-distributed column: cumulative through 12/31/2018 (198,868,169) minus cumulative through 12/31/2017 (185,428,393). Computed, not printed."
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 8841996,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"HIB\", doses-distributed column: cumulative through 12/31/2018 (128,789,396) minus cumulative through 12/31/2017 (119,947,400). Computed, not printed."
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 9965003,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"HPV\", doses-distributed column: cumulative through 12/31/2018 (121,642,555) minus cumulative through 12/31/2017 (111,677,552). Computed, not printed."
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 154000000,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Influenza\", doses-distributed column: cumulative through 12/31/2018 (1,672,400,000) minus cumulative through 12/31/2017 (1,518,400,000). Computed, not printed."
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 2574770,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"IPV\", doses-distributed column: cumulative through 12/31/2018 (75,537,282) minus cumulative through 12/31/2017 (72,962,512). Computed, not printed."
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 12120036,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Meningococcal\", doses-distributed column: cumulative through 12/31/2018 (106,233,254) minus cumulative through 12/31/2017 (94,113,218). Computed, not printed."
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 6887727,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"MMR\", doses-distributed column: cumulative through 12/31/2018 (108,389,441) minus cumulative through 12/31/2017 (101,501,714). Computed, not printed."
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 3578200,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"MMR-Varicella\", doses-distributed column: cumulative through 12/31/2018 (28,376,497) minus cumulative through 12/31/2017 (24,798,297). Computed, not printed."
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 21562290,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Pneumococcal Conjugate\", doses-distributed column: cumulative through 12/31/2018 (250,151,136) minus cumulative through 12/31/2017 (228,588,846). Computed, not printed."
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 8973144,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Rotavirus\", doses-distributed column: cumulative through 12/31/2018 (116,651,363) minus cumulative through 12/31/2017 (107,678,219). Computed, not printed."
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 2950326,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Td\", doses-distributed column: cumulative through 12/31/2018 (68,120,632) minus cumulative through 12/31/2017 (65,170,306). Computed, not printed."
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 22592482,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Tdap\", doses-distributed column: cumulative through 12/31/2018 (270,851,285) minus cumulative through 12/31/2017 (248,258,803). Computed, not printed."
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 5792094,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Varicella\", doses-distributed column: cumulative through 12/31/2018 (121,855,108) minus cumulative through 12/31/2017 (116,063,014). Computed, not printed."
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": 2018,
   "period_start": "2018-01-01",
   "period_end": "2018-12-31",
   "doses": 307474995,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 04/01/2021 minus 11/01/2019",
   "location_in_source": "Row \"Grand Total\", doses-distributed column: cumulative through 12/31/2018 (3,761,744,351) minus cumulative through 12/31/2017 (3,454,269,356). Computed, not printed."
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 4516997,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"DTaP\", doses-distributed column: cumulative through 12/31/2019 (109,991,074) minus cumulative through 12/31/2018 (105,474,077). Computed, not printed."
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 5542334,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"DTaP-Hep B-IPV\", doses-distributed column: cumulative through 12/31/2019 (79,798,141) minus cumulative through 12/31/2018 (74,255,807). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 3554694,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"DTaP-IPV\", doses-distributed column: cumulative through 12/31/2019 (31,439,498) minus cumulative through 12/31/2018 (27,884,804). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 5993980,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"DTaP-IPV-HIB\", doses-distributed column: cumulative through 12/31/2019 (74,403,716) minus cumulative through 12/31/2018 (68,409,736). Computed, not printed."
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 1022160,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Hep A-Hep B\", doses-distributed column: cumulative through 12/31/2019 (17,946,038) minus cumulative through 12/31/2018 (16,923,878). Computed, not printed."
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 13631846,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Hepatitis A (Hep A)\", doses-distributed column: cumulative through 12/31/2019 (203,339,060) minus cumulative through 12/31/2018 (189,707,214). Computed, not printed."
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 17904090,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Hepatitis B (Hep B)\", doses-distributed column: cumulative through 12/31/2019 (216,772,259) minus cumulative through 12/31/2018 (198,868,169). Computed, not printed."
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 8885919,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"HIB\", doses-distributed column: cumulative through 12/31/2019 (137,675,315) minus cumulative through 12/31/2018 (128,789,396). Computed, not printed."
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 10419751,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"HPV\", doses-distributed column: cumulative through 12/31/2019 (132,062,306) minus cumulative through 12/31/2018 (121,642,555). Computed, not printed."
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 170000000,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Influenza\", doses-distributed column: cumulative through 12/31/2019 (1,842,400,000) minus cumulative through 12/31/2018 (1,672,400,000). Computed, not printed."
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 2700250,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"IPV\", doses-distributed column: cumulative through 12/31/2019 (78,237,532) minus cumulative through 12/31/2018 (75,537,282). Computed, not printed."
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 12821231,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Meningococcal\", doses-distributed column: cumulative through 12/31/2019 (119,054,485) minus cumulative through 12/31/2018 (106,233,254). Computed, not printed."
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 8258144,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"MMR\", doses-distributed column: cumulative through 12/31/2019 (116,647,585) minus cumulative through 12/31/2018 (108,389,441). Computed, not printed."
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 3850226,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"MMR-Varicella\", doses-distributed column: cumulative through 12/31/2019 (32,226,723) minus cumulative through 12/31/2018 (28,376,497). Computed, not printed."
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 19756800,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Pneumococcal Conjugate\", doses-distributed column: cumulative through 12/31/2019 (269,907,936) minus cumulative through 12/31/2018 (250,151,136). Computed, not printed."
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 9136463,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Rotavirus\", doses-distributed column: cumulative through 12/31/2019 (125,787,826) minus cumulative through 12/31/2018 (116,651,363). Computed, not printed."
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 3288153,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Td\", doses-distributed column: cumulative through 12/31/2019 (71,408,785) minus cumulative through 12/31/2018 (68,120,632). Computed, not printed."
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 23683597,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Tdap\", doses-distributed column: cumulative through 12/31/2019 (294,534,882) minus cumulative through 12/31/2018 (270,851,285). Computed, not printed."
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 6046063,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Varicella\", doses-distributed column: cumulative through 12/31/2019 (127,901,171) minus cumulative through 12/31/2018 (121,855,108). Computed, not printed."
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": 2019,
   "period_start": "2019-01-01",
   "period_end": "2019-12-31",
   "doses": 331012698,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 08/01/2022 minus 04/01/2021",
   "location_in_source": "Row \"Grand Total\", doses-distributed column: cumulative through 12/31/2019 (4,092,757,049) minus cumulative through 12/31/2018 (3,761,744,351). Computed, not printed."
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 9597853,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"DTaP\", doses-distributed column: cumulative through 12/31/2021 (119,588,927) minus cumulative through 12/31/2019 (109,991,074). Computed, not printed."
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 9892093,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"DTaP-Hep B-IPV\", doses-distributed column: cumulative through 12/31/2021 (89,690,234) minus cumulative through 12/31/2019 (79,798,141). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 4278243,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"DTaP-IPV\", doses-distributed column: cumulative through 12/31/2021 (35,717,741) minus cumulative through 12/31/2019 (31,439,498). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 10732245,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"DTaP-IPV-HIB\", doses-distributed column: cumulative through 12/31/2021 (85,135,961) minus cumulative through 12/31/2019 (74,403,716). Computed, not printed."
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 1121574,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"Hep A-Hep B\", doses-distributed column: cumulative through 12/31/2021 (19,067,612) minus cumulative through 12/31/2019 (17,946,038). Computed, not printed."
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 18049886,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"Hepatitis A (Hep A)\", doses-distributed column: cumulative through 12/31/2021 (221,388,946) minus cumulative through 12/31/2019 (203,339,060). Computed, not printed."
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 21810311,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"Hepatitis B (Hep B)\", doses-distributed column: cumulative through 12/31/2021 (238,582,570) minus cumulative through 12/31/2019 (216,772,259). Computed, not printed."
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 14760706,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"HIB\", doses-distributed column: cumulative through 12/31/2021 (152,436,021) minus cumulative through 12/31/2019 (137,675,315). Computed, not printed."
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 17289842,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"HPV\", doses-distributed column: cumulative through 12/31/2021 (149,352,148) minus cumulative through 12/31/2019 (132,062,306). Computed, not printed."
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 389000000,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"Influenza\", doses-distributed column: cumulative through 12/31/2021 (2,231,400,000) minus cumulative through 12/31/2019 (1,842,400,000). Computed, not printed."
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 4897450,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"IPV\", doses-distributed column: cumulative through 12/31/2021 (83,134,982) minus cumulative through 12/31/2019 (78,237,532). Computed, not printed."
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 21346813,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"Meningococcal\", doses-distributed column: cumulative through 12/31/2021 (140,401,298) minus cumulative through 12/31/2019 (119,054,485). Computed, not printed."
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 11223882,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"MMR\", doses-distributed column: cumulative through 12/31/2021 (127,871,467) minus cumulative through 12/31/2019 (116,647,585). Computed, not printed."
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 6996603,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"MMR-Varicella\", doses-distributed column: cumulative through 12/31/2021 (39,223,326) minus cumulative through 12/31/2019 (32,226,723). Computed, not printed."
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 33230632,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"Pneumococcal Conjugate\", doses-distributed column: cumulative through 12/31/2021 (303,138,568) minus cumulative through 12/31/2019 (269,907,936). Computed, not printed."
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 5300868,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"Td\", doses-distributed column: cumulative through 12/31/2021 (76,709,653) minus cumulative through 12/31/2019 (71,408,785). Computed, not printed."
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 40598256,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"Tdap\", doses-distributed column: cumulative through 12/31/2021 (335,133,138) minus cumulative through 12/31/2019 (294,534,882). Computed, not printed."
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": "2020-2021",
   "period_start": "2020-01-01",
   "period_end": "2021-12-31",
   "doses": 10512915,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2023 minus 08/01/2022",
   "location_in_source": "Row \"Varicella\", doses-distributed column: cumulative through 12/31/2021 (138,414,086) minus cumulative through 12/31/2019 (127,901,171). Computed, not printed."
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 2648726,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"DTaP\", doses-distributed column: cumulative through 12/31/2022 (122,237,653) minus cumulative through 12/31/2021 (119,588,927). Computed, not printed."
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 4641351,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"DTaP-Hep B-IPV\", doses-distributed column: cumulative through 12/31/2022 (94,331,585) minus cumulative through 12/31/2021 (89,690,234). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 4738643,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"DTaP-IPV\", doses-distributed column: cumulative through 12/31/2022 (40,456,384) minus cumulative through 12/31/2021 (35,717,741). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 4432825,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"DTaP-IPV-HIB\", doses-distributed column: cumulative through 12/31/2022 (89,568,786) minus cumulative through 12/31/2021 (85,135,961). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB-Hep B",
   "counts_toward": [
    "dtap",
    "polio",
    "hib",
    "hepatitis-b"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 1557700,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"DTaP-IPV-HIB-Hep B\", doses-distributed column: cumulative through 12/31/2022 (2,021,770) minus cumulative through 12/31/2021 (464,070). Computed, not printed."
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 743895,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"Hep A-Hep B\", doses-distributed column: cumulative through 12/31/2022 (19,811,507) minus cumulative through 12/31/2021 (19,067,612). Computed, not printed."
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 9645619,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"Hepatitis A (Hep A)\", doses-distributed column: cumulative through 12/31/2022 (231,034,565) minus cumulative through 12/31/2021 (221,388,946). Computed, not printed."
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 10234232,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"Hepatitis B (Hep B)\", doses-distributed column: cumulative through 12/31/2022 (248,816,802) minus cumulative through 12/31/2021 (238,582,570). Computed, not printed."
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 7015472,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"HIB\", doses-distributed column: cumulative through 12/31/2022 (159,451,493) minus cumulative through 12/31/2021 (152,436,021). Computed, not printed."
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 9526393,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"HPV\", doses-distributed column: cumulative through 12/31/2022 (158,878,541) minus cumulative through 12/31/2021 (149,352,148). Computed, not printed."
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 175600000,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"Influenza\", doses-distributed column: cumulative through 12/31/2022 (2,407,000,000) minus cumulative through 12/31/2021 (2,231,400,000). Computed, not printed."
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 2681610,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"IPV\", doses-distributed column: cumulative through 12/31/2022 (85,816,592) minus cumulative through 12/31/2021 (83,134,982). Computed, not printed."
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 12165295,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"Meningococcal\", doses-distributed column: cumulative through 12/31/2022 (152,566,593) minus cumulative through 12/31/2021 (140,401,298). Computed, not printed."
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 6552871,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"MMR\", doses-distributed column: cumulative through 12/31/2022 (134,424,338) minus cumulative through 12/31/2021 (127,871,467). Computed, not printed."
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 3713118,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"MMR-Varicella\", doses-distributed column: cumulative through 12/31/2022 (42,936,444) minus cumulative through 12/31/2021 (39,223,326). Computed, not printed."
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 14021340,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"Pneumococcal Conjugate\", doses-distributed column: cumulative through 12/31/2022 (317,159,908) minus cumulative through 12/31/2021 (303,138,568). Computed, not printed."
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 2722540,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"Td\", doses-distributed column: cumulative through 12/31/2022 (79,432,193) minus cumulative through 12/31/2021 (76,709,653). Computed, not printed."
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 23001099,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"Tdap\", doses-distributed column: cumulative through 12/31/2022 (358,134,237) minus cumulative through 12/31/2021 (335,133,138). Computed, not printed."
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": 2022,
   "period_start": "2022-01-01",
   "period_end": "2022-12-31",
   "doses": 5491942,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 09/01/2023",
   "location_in_source": "Row \"Varicella\", doses-distributed column: cumulative through 12/31/2022 (143,906,028) minus cumulative through 12/31/2021 (138,414,086). Computed, not printed."
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 3791244,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"DTaP\", doses-distributed column: cumulative through 12/31/2023 (126,028,897) minus cumulative through 12/31/2022 (122,237,653). Computed, not printed."
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 4054369,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"DTaP-Hep B-IPV\", doses-distributed column: cumulative through 12/31/2023 (98,385,954) minus cumulative through 12/31/2022 (94,331,585). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 3304574,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"DTaP-IPV\", doses-distributed column: cumulative through 12/31/2023 (43,760,958) minus cumulative through 12/31/2022 (40,456,384). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 3584470,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"DTaP-IPV-HIB\", doses-distributed column: cumulative through 12/31/2023 (93,153,256) minus cumulative through 12/31/2022 (89,568,786). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB-Hep B",
   "counts_toward": [
    "dtap",
    "polio",
    "hib",
    "hepatitis-b"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 2317954,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"DTaP-IPV-HIB-Hep B\", doses-distributed column: cumulative through 12/31/2023 (4,339,724) minus cumulative through 12/31/2022 (2,021,770). Computed, not printed."
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 1007120,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Hep A-Hep B\", doses-distributed column: cumulative through 12/31/2023 (20,818,627) minus cumulative through 12/31/2022 (19,811,507). Computed, not printed."
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 9755144,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Hepatitis A (Hep A)\", doses-distributed column: cumulative through 12/31/2023 (240,789,709) minus cumulative through 12/31/2022 (231,034,565). Computed, not printed."
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 9674775,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Hepatitis B (Hep B)\", doses-distributed column: cumulative through 12/31/2023 (258,491,577) minus cumulative through 12/31/2022 (248,816,802). Computed, not printed."
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 6611783,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"HIB\", doses-distributed column: cumulative through 12/31/2023 (166,063,276) minus cumulative through 12/31/2022 (159,451,493). Computed, not printed."
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 8873501,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"HPV\", doses-distributed column: cumulative through 12/31/2023 (167,752,042) minus cumulative through 12/31/2022 (158,878,541). Computed, not printed."
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 173400000,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Influenza\", doses-distributed column: cumulative through 12/31/2023 (2,580,400,000) minus cumulative through 12/31/2022 (2,407,000,000). Computed, not printed."
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 2518150,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"IPV\", doses-distributed column: cumulative through 12/31/2023 (88,334,742) minus cumulative through 12/31/2022 (85,816,592). Computed, not printed."
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 11853939,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Meningococcal\", doses-distributed column: cumulative through 12/31/2023 (164,420,532) minus cumulative through 12/31/2022 (152,566,593). Computed, not printed."
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 6073673,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"MMR\", doses-distributed column: cumulative through 12/31/2023 (140,498,011) minus cumulative through 12/31/2022 (134,424,338). Computed, not printed."
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 3740726,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"MMR-Varicella\", doses-distributed column: cumulative through 12/31/2023 (46,677,170) minus cumulative through 12/31/2022 (42,936,444). Computed, not printed."
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 6656440,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Pneumococcal Conjugate\", doses-distributed column: cumulative through 12/31/2023 (323,816,348) minus cumulative through 12/31/2022 (317,159,908). Computed, not printed."
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 8263349,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Rotavirus\", doses-distributed column: cumulative through 12/31/2023 (159,130,001) minus cumulative through 12/31/2022 (150,866,652). Computed, not printed."
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 2469110,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Td\", doses-distributed column: cumulative through 12/31/2023 (81,901,303) minus cumulative through 12/31/2022 (79,432,193). Computed, not printed."
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 23535415,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Tdap\", doses-distributed column: cumulative through 12/31/2023 (381,669,652) minus cumulative through 12/31/2022 (358,134,237). Computed, not printed."
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 5750008,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Varicella\", doses-distributed column: cumulative through 12/31/2023 (149,656,036) minus cumulative through 12/31/2022 (143,906,028). Computed, not printed."
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": 2023,
   "period_start": "2023-01-01",
   "period_end": "2023-12-31",
   "doses": 297235744,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2025 minus 09/01/2024",
   "location_in_source": "Row \"Grand Total\", doses-distributed column: cumulative through 12/31/2023 (5,347,310,532) minus cumulative through 12/31/2022 (5,050,074,788). Computed, not printed."
  },
  {
   "source_category": "DTaP",
   "counts_toward": [
    "dtap"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 3653803,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"DTaP\", doses-distributed column: cumulative through 12/31/2024 (129,682,700) minus cumulative through 12/31/2023 (126,028,897). Computed, not printed."
  },
  {
   "source_category": "DTaP-Hep B-IPV",
   "counts_toward": [
    "dtap",
    "hepatitis-b",
    "polio"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 3715828,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"DTaP-Hep B-IPV\", doses-distributed column: cumulative through 12/31/2024 (102,101,782) minus cumulative through 12/31/2023 (98,385,954). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV",
   "counts_toward": [
    "dtap",
    "polio"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 3802571,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"DTaP-IPV\", doses-distributed column: cumulative through 12/31/2024 (47,563,529) minus cumulative through 12/31/2023 (43,760,958). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB",
   "counts_toward": [
    "dtap",
    "polio",
    "hib"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 3142655,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"DTaP-IPV-HIB\", doses-distributed column: cumulative through 12/31/2024 (96,295,911) minus cumulative through 12/31/2023 (93,153,256). Computed, not printed."
  },
  {
   "source_category": "DTaP-IPV-HIB-Hep B",
   "counts_toward": [
    "dtap",
    "polio",
    "hib",
    "hepatitis-b"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 2698870,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"DTaP-IPV-HIB-Hep B\", doses-distributed column: cumulative through 12/31/2024 (7,038,594) minus cumulative through 12/31/2023 (4,339,724). Computed, not printed."
  },
  {
   "source_category": "Hep A-Hep B",
   "counts_toward": [
    "hepatitis-a",
    "hepatitis-b"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 1139097,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Hep A-Hep B\", doses-distributed column: cumulative through 12/31/2024 (21,957,724) minus cumulative through 12/31/2023 (20,818,627). Computed, not printed."
  },
  {
   "source_category": "Hepatitis A (Hep A)",
   "counts_toward": [
    "hepatitis-a"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 9611065,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Hepatitis A (Hep A)\", doses-distributed column: cumulative through 12/31/2024 (250,400,774) minus cumulative through 12/31/2023 (240,789,709). Computed, not printed."
  },
  {
   "source_category": "Hepatitis B (Hep B)",
   "counts_toward": [
    "hepatitis-b"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 12274976,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Hepatitis B (Hep B)\", doses-distributed column: cumulative through 12/31/2024 (270,766,553) minus cumulative through 12/31/2023 (258,491,577). Computed, not printed."
  },
  {
   "source_category": "HIB",
   "counts_toward": [
    "hib"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 6118797,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"HIB\", doses-distributed column: cumulative through 12/31/2024 (172,182,073) minus cumulative through 12/31/2023 (166,063,276). Computed, not printed."
  },
  {
   "source_category": "HPV",
   "counts_toward": [
    "hpv"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 9705560,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"HPV\", doses-distributed column: cumulative through 12/31/2024 (177,457,602) minus cumulative through 12/31/2023 (167,752,042). Computed, not printed."
  },
  {
   "source_category": "Influenza",
   "counts_toward": [
    "influenza"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 134000000,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Influenza\", doses-distributed column: cumulative through 12/31/2024 (2,714,400,000) minus cumulative through 12/31/2023 (2,580,400,000). Computed, not printed."
  },
  {
   "source_category": "IPV",
   "counts_toward": [
    "polio"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 3288140,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"IPV\", doses-distributed column: cumulative through 12/31/2024 (91,622,882) minus cumulative through 12/31/2023 (88,334,742). Computed, not printed."
  },
  {
   "source_category": "Meningococcal",
   "counts_toward": [
    "meningococcal"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 13152683,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Meningococcal\", doses-distributed column: cumulative through 12/31/2024 (177,573,215) minus cumulative through 12/31/2023 (164,420,532). Computed, not printed."
  },
  {
   "source_category": "MMR",
   "counts_toward": [
    "mmr"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 6186758,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"MMR\", doses-distributed column: cumulative through 12/31/2024 (146,684,769) minus cumulative through 12/31/2023 (140,498,011). Computed, not printed."
  },
  {
   "source_category": "MMR-Varicella",
   "counts_toward": [
    "mmr",
    "varicella"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 3796853,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"MMR-Varicella\", doses-distributed column: cumulative through 12/31/2024 (50,474,023) minus cumulative through 12/31/2023 (46,677,170). Computed, not printed."
  },
  {
   "source_category": "Pneumococcal Conjugate",
   "counts_toward": [
    "pcv"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 47558202,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Pneumococcal Conjugate\", doses-distributed column: cumulative through 12/31/2024 (371,374,550) minus cumulative through 12/31/2023 (323,816,348). Computed, not printed."
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 8001096,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Rotavirus\", doses-distributed column: cumulative through 12/31/2024 (167,131,097) minus cumulative through 12/31/2023 (159,130,001). Computed, not printed."
  },
  {
   "source_category": "Td",
   "counts_toward": [
    "dtap"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 1969890,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Td\", doses-distributed column: cumulative through 12/31/2024 (83,871,193) minus cumulative through 12/31/2023 (81,901,303). Computed, not printed."
  },
  {
   "source_category": "Tdap",
   "counts_toward": [
    "dtap"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 25078041,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Tdap\", doses-distributed column: cumulative through 12/31/2024 (406,747,693) minus cumulative through 12/31/2023 (381,669,652). Computed, not printed."
  },
  {
   "source_category": "Varicella",
   "counts_toward": [
    "varicella"
   ],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 5790064,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Varicella\", doses-distributed column: cumulative through 12/31/2024 (155,446,100) minus cumulative through 12/31/2023 (149,656,036). Computed, not printed."
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": 2024,
   "period_start": "2024-01-01",
   "period_end": "2024-12-31",
   "doses": 304684949,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2026 minus 09/01/2025",
   "location_in_source": "Row \"Grand Total\", doses-distributed column: cumulative through 12/31/2024 (5,651,995,481) minus cumulative through 12/31/2023 (5,347,310,532). Computed, not printed."
  },
  {
   "source_category": "Rotavirus",
   "counts_toward": [
    "rotavirus"
   ],
   "year": "2020-2022",
   "period_start": "2020-01-01",
   "period_end": "2022-12-31",
   "doses": 25078826,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 08/01/2022",
   "location_in_source": "Row \"Rotavirus\": cumulative through 12/31/2022 (150,866,652) minus through 12/31/2019 (125,787,826); spans 3 years because the through-2021 edition prints a suspected erroneous value. Computed."
  },
  {
   "source_category": "Grand Total",
   "counts_toward": [],
   "year": "2020-2022",
   "period_start": "2020-01-01",
   "period_end": "2022-12-31",
   "doses": 957317739,
   "measure": "distributed",
   "value_type": "derived_difference_of_cumulative_editions",
   "source": "HRSA VICP Monthly Statistics Reports updated 09/01/2024 minus 08/01/2022",
   "location_in_source": "Row \"Grand Total\": cumulative through 12/31/2022 (5,050,074,788) minus through 12/31/2019 (4,092,757,049); spans 3 years because the through-2021 edition prints a suspected erroneous value. Computed."
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2011-2012",
   "season": "2011-2012",
   "doses": 132100000,
   "doses_as_printed": "≈ 132.1 million doses",
   "measure": "distributed",
   "value_type": "season_cumulative_final_weekly_update",
   "source": "CDC 2011-2012 Seasonal Influenza Vaccine Total Doses Distributed (archived page)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/vaccinesupply-2011.htm",
   "location_in_source": "Weekly cumulative doses table, last row (week of 02/03/2012); page marks this the final weekly update for the season (2014-15 page: latest row shown); printed as approximate"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2012-2013",
   "season": "2012-2013",
   "doses": 134900000,
   "doses_as_printed": "≈ 134.9 million doses",
   "measure": "distributed",
   "value_type": "season_cumulative_final_weekly_update",
   "source": "CDC 2012-2013 Seasonal Influenza Vaccine Total Doses Distributed (archived page)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/vaccinesupply-2012.htm",
   "location_in_source": "Weekly cumulative doses table, last row (week of 03/01/2013); page marks this the final weekly update for the season (2014-15 page: latest row shown); printed as approximate"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2013-2014",
   "season": "2013-2014",
   "doses": 134500000,
   "doses_as_printed": "≈ 134.5 million doses",
   "measure": "distributed",
   "value_type": "season_cumulative_final_weekly_update",
   "source": "CDC 2013-2014 Seasonal Influenza Vaccine Total Doses Distributed (archived page)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/vaccinesupply-2013.htm",
   "location_in_source": "Weekly cumulative doses table, last row (week of 02/28/2014); page marks this the final weekly update for the season (2014-15 page: latest row shown); printed as approximate"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2014-2015",
   "season": "2014-2015",
   "doses": 147800000,
   "doses_as_printed": "≈ 147.8 million doses",
   "measure": "distributed",
   "value_type": "season_cumulative_final_weekly_update",
   "source": "CDC 2014-2015 Seasonal Influenza Vaccine Total Doses Distributed (archived page)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/vaccinesupply-2014.htm",
   "location_in_source": "Weekly cumulative doses table, last row (week of 02/06/2015); page marks this the final weekly update for the season (2014-15 page: latest row shown); printed as approximate"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2015-2016",
   "season": "2015-2016",
   "doses": 146400000,
   "doses_as_printed": "≈ 146.4 million doses",
   "measure": "distributed",
   "value_type": "season_cumulative_final_weekly_update",
   "source": "CDC 2015-2016 Seasonal Influenza Vaccine Total Doses Distributed (archived page)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/vaccinesupply-2015.htm",
   "location_in_source": "Weekly cumulative doses table, last row (week of 02/26/2016); page marks this the final weekly update for the season (2014-15 page: latest row shown); printed as approximate"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2016-2017",
   "season": "2016-2017",
   "doses": 145900000,
   "doses_as_printed": "≈ 145.9 million doses",
   "measure": "distributed",
   "value_type": "season_cumulative_final_weekly_update",
   "source": "CDC 2016-2017 Seasonal Influenza Vaccine Total Doses Distributed (archived page)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/vaccinesupply-2016.htm",
   "location_in_source": "Weekly cumulative doses table, last row (week of 03/03/2017); page marks this the final weekly update for the season (2014-15 page: latest row shown); printed as approximate"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2017-2018",
   "season": "2017-2018",
   "doses": 155300000,
   "doses_as_printed": "≈ 155.3 million doses",
   "measure": "distributed",
   "value_type": "season_cumulative_final_weekly_update",
   "source": "CDC 2017-2018 Seasonal Influenza Vaccine Total Doses Distributed (archived page)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/vaccinesupply-2017.htm",
   "location_in_source": "Weekly cumulative doses table, last row (week of 02/23/2018); page marks this the final weekly update for the season (2014-15 page: latest row shown); printed as approximate"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2018-2019",
   "season": "2018-2019",
   "doses": 170730000,
   "doses_as_printed": "170.73 (millions)",
   "measure": "distributed",
   "value_type": "season_cumulative_max_week",
   "source": "CDC FluVaxView: Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season, United States (data.cdc.gov ph8r-wzxn)",
   "url": "https://data.cdc.gov/Flu-Vaccinations/Weekly-Cumulative-Doses-in-Millions-of-Influenza-V/ph8r-wzxn/about_data",
   "location_in_source": "Column Cumulative_Flu_Doses_Distributed, Influenza_Season=2018-2019, maximum value (week ending 03/09/2019, Week_Sort_Order 32); CSV downloaded 2026-10-09"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2019-2020",
   "season": "2019-2020",
   "doses": 175150000,
   "doses_as_printed": "175.15 (millions)",
   "measure": "distributed",
   "value_type": "season_cumulative_max_week",
   "source": "CDC FluVaxView: Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season, United States (data.cdc.gov ph8r-wzxn)",
   "url": "https://data.cdc.gov/Flu-Vaccinations/Weekly-Cumulative-Doses-in-Millions-of-Influenza-V/ph8r-wzxn/about_data",
   "location_in_source": "Column Cumulative_Flu_Doses_Distributed, Influenza_Season=2019-2020, maximum value (week ending 03/07/2020, Week_Sort_Order 32); CSV downloaded 2026-10-09"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2020-2021",
   "season": "2020-2021",
   "doses": 194390000,
   "doses_as_printed": "194.39 (millions)",
   "measure": "distributed",
   "value_type": "season_cumulative_max_week",
   "source": "CDC FluVaxView: Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season, United States (data.cdc.gov ph8r-wzxn)",
   "url": "https://data.cdc.gov/Flu-Vaccinations/Weekly-Cumulative-Doses-in-Millions-of-Influenza-V/ph8r-wzxn/about_data",
   "location_in_source": "Column Cumulative_Flu_Doses_Distributed, Influenza_Season=2020-2021, maximum value (week ending 03/06/2021, Week_Sort_Order 32); CSV downloaded 2026-10-09"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2021-2022",
   "season": "2021-2022",
   "doses": 175620000,
   "doses_as_printed": "175.62 (millions)",
   "measure": "distributed",
   "value_type": "season_cumulative_max_week",
   "source": "CDC FluVaxView: Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season, United States (data.cdc.gov ph8r-wzxn)",
   "url": "https://data.cdc.gov/Flu-Vaccinations/Weekly-Cumulative-Doses-in-Millions-of-Influenza-V/ph8r-wzxn/about_data",
   "location_in_source": "Column Cumulative_Flu_Doses_Distributed, Influenza_Season=2021-2022, maximum value (week ending 03/05/2022, Week_Sort_Order 32); CSV downloaded 2026-10-09"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2022-2023",
   "season": "2022-2023",
   "doses": 173370000,
   "doses_as_printed": "173.37 (millions)",
   "measure": "distributed",
   "value_type": "season_cumulative_max_week",
   "source": "CDC FluVaxView: Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season, United States (data.cdc.gov ph8r-wzxn)",
   "url": "https://data.cdc.gov/Flu-Vaccinations/Weekly-Cumulative-Doses-in-Millions-of-Influenza-V/ph8r-wzxn/about_data",
   "location_in_source": "Column Cumulative_Flu_Doses_Distributed, Influenza_Season=2022-2023, maximum value (week ending 03/04/2023, Week_Sort_Order 32); CSV downloaded 2026-10-09"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2023-2024",
   "season": "2023-2024",
   "doses": 157720000,
   "doses_as_printed": "157.72 (millions)",
   "measure": "distributed",
   "value_type": "season_cumulative_max_week",
   "source": "CDC FluVaxView: Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season, United States (data.cdc.gov ph8r-wzxn)",
   "url": "https://data.cdc.gov/Flu-Vaccinations/Weekly-Cumulative-Doses-in-Millions-of-Influenza-V/ph8r-wzxn/about_data",
   "location_in_source": "Column Cumulative_Flu_Doses_Distributed, Influenza_Season=2023-2024, maximum value (week ending 03/09/2024, Week_Sort_Order 32); CSV downloaded 2026-10-09"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2024-2025",
   "season": "2024-2025",
   "doses": 147550000,
   "doses_as_printed": "147.55 (millions)",
   "measure": "distributed",
   "value_type": "season_cumulative_max_week",
   "source": "CDC FluVaxView: Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season, United States (data.cdc.gov ph8r-wzxn)",
   "url": "https://data.cdc.gov/Flu-Vaccinations/Weekly-Cumulative-Doses-in-Millions-of-Influenza-V/ph8r-wzxn/about_data",
   "location_in_source": "Column Cumulative_Flu_Doses_Distributed, Influenza_Season=2024-2025, maximum value (week ending 03/08/2025, Week_Sort_Order 32); CSV downloaded 2026-10-09"
  },
  {
   "source_category": "Seasonal influenza (all products)",
   "counts_toward": [
    "influenza"
   ],
   "year": "2025-2026",
   "season": "2025-2026",
   "doses": 135600000,
   "doses_as_printed": "135.6 (millions)",
   "measure": "distributed",
   "value_type": "season_cumulative_max_week",
   "source": "CDC FluVaxView: Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season, United States (data.cdc.gov ph8r-wzxn)",
   "url": "https://data.cdc.gov/Flu-Vaccinations/Weekly-Cumulative-Doses-in-Millions-of-Influenza-V/ph8r-wzxn/about_data",
   "location_in_source": "Column Cumulative_Flu_Doses_Distributed, Influenza_Season=2025-2026, maximum value (week ending 03/07/2026, Week_Sort_Order 32); CSV downloaded 2026-10-09",
   "note": "Latest value in dataset (as of 03/07/2026); may not be the final season total."
  },
  {
   "source_category": "Seasonal influenza (all products) - original unadjusted total",
   "counts_toward": [
    "influenza"
   ],
   "year": "2021-2022",
   "season": "2021-2022",
   "doses": 174900000,
   "doses_as_printed": "174.9 (millions); revised 175.6",
   "measure": "distributed",
   "value_type": "season_total_unadjusted",
   "source": "CDC Adjusted and Unadjusted Flu Vaccine Doses Distributed: 2018-2019 - 2021-2022 (last reviewed January 6, 2023)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/unadjusted-archive.htm",
   "location_in_source": "Table row 2021-2022, column \"Original Total (millions)\"; the \"Revised Total\" matches the data.cdc.gov rows"
  },
  {
   "source_category": "Seasonal influenza (all products) - original unadjusted total",
   "counts_toward": [
    "influenza"
   ],
   "year": "2020-2021",
   "season": "2020-2021",
   "doses": 193800000,
   "doses_as_printed": "193.8 (millions); revised 194.4",
   "measure": "distributed",
   "value_type": "season_total_unadjusted",
   "source": "CDC Adjusted and Unadjusted Flu Vaccine Doses Distributed: 2018-2019 - 2021-2022 (last reviewed January 6, 2023)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/unadjusted-archive.htm",
   "location_in_source": "Table row 2020-2021, column \"Original Total (millions)\"; the \"Revised Total\" matches the data.cdc.gov rows"
  },
  {
   "source_category": "Seasonal influenza (all products) - original unadjusted total",
   "counts_toward": [
    "influenza"
   ],
   "year": "2019-2020",
   "season": "2019-2020",
   "doses": 174500000,
   "doses_as_printed": "174.5 (millions); revised 175.2",
   "measure": "distributed",
   "value_type": "season_total_unadjusted",
   "source": "CDC Adjusted and Unadjusted Flu Vaccine Doses Distributed: 2018-2019 - 2021-2022 (last reviewed January 6, 2023)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/unadjusted-archive.htm",
   "location_in_source": "Table row 2019-2020, column \"Original Total (millions)\"; the \"Revised Total\" matches the data.cdc.gov rows"
  },
  {
   "source_category": "Seasonal influenza (all products) - original unadjusted total",
   "counts_toward": [
    "influenza"
   ],
   "year": "2018-2019",
   "season": "2018-2019",
   "doses": 169100000,
   "doses_as_printed": "169.1 (millions); revised 170.7",
   "measure": "distributed",
   "value_type": "season_total_unadjusted",
   "source": "CDC Adjusted and Unadjusted Flu Vaccine Doses Distributed: 2018-2019 - 2021-2022 (last reviewed January 6, 2023)",
   "url": "https://archive.cdc.gov/www_cdc_gov/flu/prevent/unadjusted-archive.htm",
   "location_in_source": "Table row 2018-2019, column \"Original Total (millions)\"; the \"Revised Total\" matches the data.cdc.gov rows"
  },
  {
   "source_category": "COVID-19 (all manufacturers)",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2020-12-31",
   "period_start": "2020-12-14",
   "period_end": "2020-12-31",
   "doses": 3738130,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2020-12-31, location=US, column administered; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 Pfizer-BioNTech",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2020-12-31",
   "period_start": "2020-12-14",
   "period_end": "2020-12-31",
   "doses": 2630115,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2020-12-31, location=US, column administered_pfizer; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 Moderna",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2020-12-31",
   "period_start": "2020-12-14",
   "period_end": "2020-12-31",
   "doses": 1107143,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2020-12-31, location=US, column administered_moderna; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 Janssen (J&J)",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2020-12-31",
   "period_start": "2020-12-14",
   "period_end": "2020-12-31",
   "doses": 0,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2020-12-31, location=US, column administered_janssen; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 unknown manufacturer",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2020-12-31",
   "period_start": "2020-12-14",
   "period_end": "2020-12-31",
   "doses": 872,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2020-12-31, location=US, column administered_unk_manuf; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 (all manufacturers)",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2021-12-31",
   "period_start": "2020-12-14",
   "period_end": "2021-12-31",
   "doses": 509307789,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2021-12-31, location=US, column administered; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 Pfizer-BioNTech",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2021-12-31",
   "period_start": "2020-12-14",
   "period_end": "2021-12-31",
   "doses": 296870831,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2021-12-31, location=US, column administered_pfizer; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 Moderna",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2021-12-31",
   "period_start": "2020-12-14",
   "period_end": "2021-12-31",
   "doses": 194260394,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2021-12-31, location=US, column administered_moderna; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 Janssen (J&J)",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2021-12-31",
   "period_start": "2020-12-14",
   "period_end": "2021-12-31",
   "doses": 17640334,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2021-12-31, location=US, column administered_janssen; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 unknown manufacturer",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2021-12-31",
   "period_start": "2020-12-14",
   "period_end": "2021-12-31",
   "doses": 536230,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2021-12-31, location=US, column administered_unk_manuf; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 (all manufacturers)",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2022-12-28",
   "period_start": "2020-12-14",
   "period_end": "2022-12-28",
   "doses": 663822575,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2022-12-28, location=US, column administered; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 Pfizer-BioNTech",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2022-12-28",
   "period_start": "2020-12-14",
   "period_end": "2022-12-28",
   "doses": 395452177,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2022-12-28, location=US, column administered_pfizer; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 Moderna",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2022-12-28",
   "period_start": "2020-12-14",
   "period_end": "2022-12-28",
   "doses": 248567365,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2022-12-28, location=US, column administered_moderna; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 Janssen (J&J)",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2022-12-28",
   "period_start": "2020-12-14",
   "period_end": "2022-12-28",
   "doses": 18952708,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2022-12-28, location=US, column administered_janssen; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 Novavax",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2022-12-28",
   "period_start": "2020-12-14",
   "period_end": "2022-12-28",
   "doses": 69062,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2022-12-28, location=US, column administered_novavax; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 unknown manufacturer",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2022-12-28",
   "period_start": "2020-12-14",
   "period_end": "2022-12-28",
   "doses": 781263,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2022-12-28, location=US, column administered_unk_manuf; queried via data.cdc.gov SODA API 2026-10-09"
  },
  {
   "source_category": "COVID-19 (all manufacturers)",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 676728782,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column administered; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 Pfizer-BioNTech",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 366979906,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column administered_pfizer; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 Moderna",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 232147784,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column administered_moderna; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 Janssen (J&J)",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 19007537,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column administered_janssen; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 Novavax",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 89195,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column administered_novavax; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 unknown manufacturer",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 890835,
   "measure": "administered",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column administered_unk_manuf; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 (all manufacturers)",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 984444295,
   "measure": "distributed",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column distributed; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 Pfizer-BioNTech",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 505345015,
   "measure": "distributed",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column distributed_pfizer; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 Moderna",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 313437660,
   "measure": "distributed",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column distributed_moderna; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 Janssen (J&J)",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 31552000,
   "measure": "distributed",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column distributed_janssen; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 Novavax",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 1410700,
   "measure": "distributed",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column distributed_novavax; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 unknown manufacturer",
   "counts_toward": [
    "covid"
   ],
   "year": "cumulative to 2023-05-10",
   "period_start": "2020-12-14",
   "period_end": "2023-05-10",
   "doses": 0,
   "measure": "distributed",
   "value_type": "cumulative_as_reported",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Row date=2023-05-10, location=US, column distributed_unk_manuf; queried via data.cdc.gov SODA API 2026-10-09",
   "note": "Final row in dataset (reporting ended May 2023). Pfizer/Moderna administered values here are LOWER than at 2022-12-28, so the manufacturer columns appear to have changed definition (possibly bivalent doses split out); the all-manufacturer total keeps rising. distributed_* by manufacturer sum to less than total distributed."
  },
  {
   "source_category": "COVID-19 (all manufacturers)",
   "counts_toward": [
    "covid"
   ],
   "year": 2021,
   "period_start": "2020-12-31",
   "period_end": "2021-12-31",
   "doses": 505569659,
   "measure": "administered",
   "value_type": "derived_difference_of_cumulative",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Column administered, location=US: 2021-12-31 (509,307,789) minus 2020-12-31 (3,738,130). Computed."
  },
  {
   "source_category": "COVID-19 (all manufacturers)",
   "counts_toward": [
    "covid"
   ],
   "year": 2022,
   "period_start": "2021-12-31",
   "period_end": "2022-12-28",
   "doses": 154514786,
   "measure": "administered",
   "value_type": "derived_difference_of_cumulative",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Column administered, location=US: 2022-12-28 (663,822,575) minus 2021-12-31 (509,307,789). Computed."
  },
  {
   "source_category": "COVID-19 (all manufacturers)",
   "counts_toward": [
    "covid"
   ],
   "year": "2023 (Jan-May 10, approx.)",
   "period_start": "2022-12-28",
   "period_end": "2023-05-10",
   "doses": 12906207,
   "measure": "administered",
   "value_type": "derived_difference_of_cumulative",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Column administered, location=US: 2023-05-10 (676,728,782) minus 2022-12-28 (663,822,575). Computed."
  },
  {
   "source_category": "COVID-19 Pfizer-BioNTech",
   "counts_toward": [
    "covid"
   ],
   "year": 2021,
   "period_start": "2020-12-31",
   "period_end": "2021-12-31",
   "doses": 294240716,
   "measure": "administered",
   "value_type": "derived_difference_of_cumulative",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Column administered_pfizer, location=US: 2021-12-31 minus 2020-12-31. Computed."
  },
  {
   "source_category": "COVID-19 Moderna",
   "counts_toward": [
    "covid"
   ],
   "year": 2021,
   "period_start": "2020-12-31",
   "period_end": "2021-12-31",
   "doses": 193153251,
   "measure": "administered",
   "value_type": "derived_difference_of_cumulative",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Column administered_moderna, location=US: 2021-12-31 minus 2020-12-31. Computed."
  },
  {
   "source_category": "COVID-19 Janssen (J&J)",
   "counts_toward": [
    "covid"
   ],
   "year": 2021,
   "period_start": "2020-12-31",
   "period_end": "2021-12-31",
   "doses": 17640334,
   "measure": "administered",
   "value_type": "derived_difference_of_cumulative",
   "source": "CDC COVID-19 Vaccinations in the United States, Jurisdiction (data.cdc.gov unsk-b7fc), location=US",
   "url": "https://data.cdc.gov/Vaccinations/COVID-19-Vaccinations-in-the-United-States-Jurisdi/unsk-b7fc",
   "location_in_source": "Column administered_janssen, location=US: 2021-12-31 minus 2020-12-31. Computed."
  },
  {
   "source_category": "RSV vaccine, adults >=60 (Arexvy + Abrysvo)",
   "counts_toward": [
    "rsv"
   ],
   "year": "2023-08-04 to 2024-03-30",
   "period_start": "2023-08-04",
   "period_end": "2024-03-30",
   "doses": 10600000,
   "doses_as_printed": "at least 10.6 million adults aged >=60 years received a recommended RSV vaccine",
   "measure": "administered",
   "value_type": "projected_administered_IQVIA",
   "source": "Hause AM, Moro PL, Baggs J, et al. Early Safety Findings Among Persons Aged >=60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024. MMWR 2024;73(21):489-494",
   "url": "https://www.cdc.gov/mmwr/volumes/73/wr/mm7321a3.htm",
   "location_in_source": "Abstract; footnote: projected doses from IQVIA medical claims (physician offices, Aug 4 2023-Mar 30 2024, data through Apr 6 2024) and IQVIA prescription claims (retail pharmacies, Aug 12 2023-Mar 29 2024); excludes public health clinics, workplaces, community sites. Adults >=60 only (maternal Abrysvo not included). Article later corrected (erratum mm7327a4)."
  },
  {
   "source_category": "Arexvy (GSK RSVPreF3)",
   "counts_toward": [
    "rsv"
   ],
   "year": "2023-08-04 to 2024-03-30",
   "period_start": "2023-08-04",
   "period_end": "2024-03-30",
   "doses": 7200000,
   "doses_as_printed": "approximately 7.2 million adults aged >=60 years received GSK RSV vaccine",
   "measure": "administered",
   "value_type": "projected_administered_IQVIA",
   "source": "Hause AM, Moro PL, Baggs J, et al. Early Safety Findings Among Persons Aged >=60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024. MMWR 2024;73(21):489-494",
   "url": "https://www.cdc.gov/mmwr/volumes/73/wr/mm7321a3.htm",
   "location_in_source": "Introduction; footnote: projected doses from IQVIA medical claims (physician offices, Aug 4 2023-Mar 30 2024, data through Apr 6 2024) and IQVIA prescription claims (retail pharmacies, Aug 12 2023-Mar 29 2024); excludes public health clinics, workplaces, community sites. Adults >=60 only (maternal Abrysvo not included). Article later corrected (erratum mm7327a4)."
  },
  {
   "source_category": "Abrysvo (Pfizer RSVpreF)",
   "counts_toward": [
    "rsv"
   ],
   "year": "2023-08-04 to 2024-03-30",
   "period_start": "2023-08-04",
   "period_end": "2024-03-30",
   "doses": 3400000,
   "doses_as_printed": "3.4 million received Pfizer RSV vaccine",
   "measure": "administered",
   "value_type": "projected_administered_IQVIA",
   "source": "Hause AM, Moro PL, Baggs J, et al. Early Safety Findings Among Persons Aged >=60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024. MMWR 2024;73(21):489-494",
   "url": "https://www.cdc.gov/mmwr/volumes/73/wr/mm7321a3.htm",
   "location_in_source": "Introduction; footnote: projected doses from IQVIA medical claims (physician offices, Aug 4 2023-Mar 30 2024, data through Apr 6 2024) and IQVIA prescription claims (retail pharmacies, Aug 12 2023-Mar 29 2024); excludes public health clinics, workplaces, community sites. Adults >=60 only (maternal Abrysvo not included). Article later corrected (erratum mm7327a4)."
  },
  {
   "source_category": "Shingrix (recombinant zoster vaccine, RZV)",
   "counts_toward": [
    "shingles"
   ],
   "year": "2017-10 to 2018-06",
   "period_start": "2017-10-01",
   "period_end": "2018-06-30",
   "doses": 3200000,
   "doses_as_printed": "approximately 3.2 million RZV doses were distributed (GlaxoSmithKline, personal communication, 2018)",
   "measure": "distributed",
   "value_type": "manufacturer_reported",
   "source": "Hesse EM, Shimabukuro TT, Su JR, et al. Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018. MMWR 2019;68(4):91-94",
   "url": "https://www.cdc.gov/mmwr/volumes/68/wr/mm6804a4.htm",
   "location_in_source": "Results text, \"first 8 months of use\" (surveillance period Oct 2017-Jun 2018); GSK personal communication. MMWR reports 136 VAERS reports per 100,000 doses distributed."
  }
 ],
 "not_found": [
  "HRSA per-year doses table: HRSA does not publish one, only cumulative totals since 2006.",
  "HRSA cumulative through 12/31/2020: never printed, so 2020 cannot be separated from 2021.",
  "HRSA per-year values for 2006-2014: only the 2006-2014 cumulative is available (the earliest edition read is updated 01/01/2017). Editions with earlier endpoints were not retrieved.",
  "HRSA cumulative through 2025: not yet published as of the 09/01/2026 edition.",
  "Rotavirus for 2020-2021 and for 2022 separately: the source value is a suspected typo, so only the 2020-2022 combined increment is given.",
  "Shingles (Shingrix/Zostavax): not in the HRSA table. The only verified U.S. figure is 3.2M RZV doses distributed Oct 2017-Jun 2018. A \"~12M doses distributed\" figure attributed to a Feb 2021 ACIP deck was NOT found in the slide text and is excluded. No annual Shingrix series was found.",
  "RSV: only the MMWR projection for adults >=60, Aug 2023-Mar 2024, was found. Not found: the 2024-25 and later seasons, maternal Abrysvo doses, and mResvia (Moderna).",
  "COVID-19: no CDC national doses-administered series after 2023-05-10. Manufacturer-level increments for 2022 and 2023 were not derived because those columns do not rise consistently.",
  "CDC influenza doses distributed, seasons 2006-07 through 2010-11: the CDC historical-reference page shows only a chart with no readable numbers, and the archived 2010 season page returned 404.",
  "PPSV23 (pneumococcal polysaccharide) and Zostavax distribution: not separately reported in any source read."
 ]
}